ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 437 filers reported holding ENCOMPASS HEALTH CORP in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,285,225 | -0.8% | 242,484 | 0.0% | 0.02% | +5.6% |
Q2 2023 | $16,418,592 | +1.7% | 242,484 | -18.8% | 0.02% | -5.3% |
Q1 2023 | $16,145,929 | +3.1% | 298,446 | +14.0% | 0.02% | 0.0% |
Q4 2022 | $15,661,847 | +32.0% | 261,860 | -0.2% | 0.02% | +26.7% |
Q3 2022 | $11,868,000 | -19.4% | 262,389 | -0.1% | 0.02% | -16.7% |
Q2 2022 | $14,726,000 | -29.6% | 262,723 | -10.7% | 0.02% | -14.3% |
Q1 2022 | $20,915,000 | +72.6% | 294,125 | +58.4% | 0.02% | +75.0% |
Q4 2021 | $12,116,000 | -22.4% | 185,652 | -10.8% | 0.01% | -29.4% |
Q3 2021 | $15,621,000 | -16.4% | 208,164 | -13.1% | 0.02% | -15.0% |
Q2 2021 | $18,694,000 | +44.2% | 239,572 | +51.4% | 0.02% | +33.3% |
Q1 2021 | $12,963,000 | +1.4% | 158,273 | +2.3% | 0.02% | -6.2% |
Q4 2020 | $12,790,000 | +1278900.0% | 154,676 | +813984.2% | 0.02% | – |
Q4 2019 | $1,000 | 0.0% | 19 | +26.7% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 15 | +50.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 10 | -44.4% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 18 | -40.0% | 0.00% | – |
Q3 2018 | $2,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 400,000 | $25,612,000 | 9.91% |
REINHART PARTNERS, LLC. | 687,133 | $43,997,000 | 4.26% |
RK Capital | 147,290 | $9,431,000 | 4.24% |
HealthCor Management, L.P. | 1,525,809 | $97,698,000 | 4.18% |
Integral Health Asset Management, LLC | 115,000 | $7,363,000 | 3.24% |
Sivik Global Healthcare LLC | 32,500 | $7,733,000 | 3.05% |
Copeland Capital Management, LLC | 635,514 | $40,692,000 | 2.48% |
Rock Springs Capital Management LP | 815,000 | $52,184,000 | 2.16% |
Endurant Capital Management LP | 55,614 | $3,561,000 | 1.61% |
Advantage Alpha Capital Partners LP | 70,005 | $4,482,000 | 1.60% |